Search

Search Constraints

You searched for: Author/Creator Dimopoulos, Meletios A

Search Results

31. Overall survival of patients with relapsed multiple myeloma treated with panobinostat or placebo plus bortezomib and dexamethasone (the PANORAMA 1 trial): a randomised, placebo-controlled, phase 3 trial. Issue 11 (November 2016)

32. Overall survival with daratumumab, bortezomib, melphalan, and prednisone in newly diagnosed multiple myeloma (ALCYONE): a randomised, open-label, phase 3 trial. Issue 10218 (11th January 2020)

33. Panobinostat: a novel pan-deacetylase inhibitor for the treatment of relapsed or relapsed and refractory multiple myeloma. Issue 7 (July 2015)

34. Personalised progression prediction in patients with monoclonal gammopathy of undetermined significance or smouldering multiple myeloma (PANGEA): a retrospective, multicohort study. Issue 3 (March 2023)

38. Treatment and outcome patterns in European patients with Waldenström's macroglobulinaemia: a large, observational, retrospective chart review. Issue 7 (July 2018)

39. Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. Issue 3 (March 2021)

40. Treatment of relapsed and refractory multiple myeloma: recommendations from the International Myeloma Working Group. Issue 3 (March 2021)